Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjolein J E Greuter

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Gastroenterology|March 2, 2025
ReplyFrancine van Wifferen, Marjolein J E Greuter, Veerle M H Coupé
Endoscopy International Open|December 5, 2017
Implementation of an optical diagnosis strategy saves costs and does not impair clinical outcomes of a fecal immunochemical test-based colorectal cancer screening programJasper L A Vleugels, Marjolein J E Greuter, Yark Hazewinkel, et al.
Annals of Internal Medicine|October 4, 2017
Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness AnalysisMarjolein J E Greuter, Clasine M de Klerk, Gerrit A Meijer, et al.
BMC Public Health|September 24, 2016
Resilience of a FIT screening programme against screening fatigue: a modelling studyMarjolein J E Greuter, Johannes Berkhof, Karen Canfell, et al.
BMC Pregnancy and Childbirth|June 30, 2012
Quality of guidelines on the management of diabetes in pregnancy: a systematic reviewMarjolein J E Greuter, Nathalie M A van Emmerik, Maurice G A J Wouters, et al.
Rheumatology (Oxford, England)|February 17, 2023
Self-monitoring combined with patient-initiated care in RA patients with low disease activity: cost-effectiveness analysis of an RCTBart F Seppen, Marjolein J E Greuter, Jimmy Wiegel, et al.
BMC Cancer|April 27, 2018
Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screeningMaxime E S Bronzwaer, Marjolein J E Greuter, Arne G C Bleijenberg, et al.
Therapeutic Advances in Gastroenterology|March 31, 2021
Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patientsGabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
Therapeutic Advances in Gastroenterology|September 30, 2020
Model-based evaluation of the cost effectiveness of 3 <i>versus</i> 6 months' adjuvant chemotherapy in high-risk stage II colon cancer patientsGabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
Gastrointestinal Endoscopy|April 22, 2021
Guidance for setting easy-to-adopt competence criteria for optical diagnosis of diminutive colorectal polyps: a simulation approachBritt B S L Houwen, Marjolein J E Greuter, Jasper L A Vleugels, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Gastroenterology|March 2, 2025
ReplyFrancine van Wifferen, Marjolein J E Greuter, Veerle M H Coupé
Endoscopy International Open|December 5, 2017
Implementation of an optical diagnosis strategy saves costs and does not impair clinical outcomes of a fecal immunochemical test-based colorectal cancer screening programJasper L A Vleugels, Marjolein J E Greuter, Yark Hazewinkel, et al.
Annals of Internal Medicine|October 4, 2017
Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness AnalysisMarjolein J E Greuter, Clasine M de Klerk, Gerrit A Meijer, et al.
BMC Public Health|September 24, 2016
Resilience of a FIT screening programme against screening fatigue: a modelling studyMarjolein J E Greuter, Johannes Berkhof, Karen Canfell, et al.
BMC Pregnancy and Childbirth|June 30, 2012
Quality of guidelines on the management of diabetes in pregnancy: a systematic reviewMarjolein J E Greuter, Nathalie M A van Emmerik, Maurice G A J Wouters, et al.
Rheumatology (Oxford, England)|February 17, 2023
Self-monitoring combined with patient-initiated care in RA patients with low disease activity: cost-effectiveness analysis of an RCTBart F Seppen, Marjolein J E Greuter, Jimmy Wiegel, et al.
BMC Cancer|April 27, 2018
Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screeningMaxime E S Bronzwaer, Marjolein J E Greuter, Arne G C Bleijenberg, et al.
Therapeutic Advances in Gastroenterology|March 31, 2021
Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patientsGabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
Therapeutic Advances in Gastroenterology|September 30, 2020
Model-based evaluation of the cost effectiveness of 3 <i>versus</i> 6 months' adjuvant chemotherapy in high-risk stage II colon cancer patientsGabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
Gastrointestinal Endoscopy|April 22, 2021
Guidance for setting easy-to-adopt competence criteria for optical diagnosis of diminutive colorectal polyps: a simulation approachBritt B S L Houwen, Marjolein J E Greuter, Jasper L A Vleugels, et al.
Pageof 4